Skip to main content
ResMed Inc. (LON:0KW4)
London flag London · Delayed Price · Currency is GBP · Price in USD
256.01
+5.10 (2.03%)
Dec 5, 2025, 4:47 PM BST

ResMed Revenue

ResMed had revenue of $1.34B USD in the quarter ending September 30, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to $5.26B, up 9.36% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.

Revenue (ttm)
$5.26B
Revenue Growth
+9.36%
P/S Ratio
7.18
Revenue / Employee
$495.98K
Employees
10,600
Market Cap
28.07B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.24B
GSK plc 32.17B
Haleon 11.02B
Smith & Nephew 4.33B
Convatec Group 1.72B
Hikma Pharmaceuticals 2.35B
HUTCHMED (China) 439.54M
Genus 672.80M
Revenue Rankings

ResMed News

More News